Abstract

RNA binding motif protein 8A (RBM8A) is an RNA binding protein in a core component of the exon junction complex. Abnormal RBM8A expression is associated with carcinogenesis. We used sequencing data from the Cancer Genome Atlas database and Gene Expression Omnibus, analyzed RBM8A expression and gene regulation networks in hepatocellular carcinoma (HCC). Expression was analyzed using OncomineTM and Gene Expression Profiling Interactive Analysis tools, while RBM8A alterations and related functional networks were identified using cBioPortal. LinkedOmics was used to identify differential gene expression with RBM8A and to analyze Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. Gene enrichment analysis examined target networks of kinases, miRNAs and transcription factors. We found that RBM8A is overexpressed and the RBM8A gene often amplified in HCC. Expression of this gene is linked to functional networks involving the ribosome and RNA metabolic signaling pathways. Functional network analysis suggested that RBM8A regulates the spliceosome, ribosome, DNA replication and cell cycle signaling via pathways involving several cancer-related kinases, miRNAs and E2F Transcription Factor 1. Our results demonstrate that data mining efficiently reveals information about RBM8A expression and potential regulatory networks in HCC, laying a foundation for further study of the role of RBM8A in carcinogenesis.

Highlights

  • Hepatocellular carcinoma (HCC) is one of the top ten malignant tumors and the third leading cause of cancerrelated death in the world [1]

  • In our studies with patient samples from Guangxi, one of the regions with the highest incidence of hepatocellular carcinoma (HCC) in China, we found that RNA binding motif protein 8A (RBM8A) was overexpressed in HCC tumor tissues compared to normal liver tissues, and this overexpression was associated with the surface antigen of the hepatitis B virus (HBsAg) and Edmondson pathological grading

  • Data in the Oncomine 4.5 database revealed that mRNA expression and DNA copy number variation (CNV) of RBM8A were significantly higher in HCC tissues than in normal tissues (p 0.01)

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is one of the top ten malignant tumors and the third leading cause of cancerrelated death in the world [1]. China accounts for 55% of new HCC cases and HCC-related deaths every year [2]. Due to the high recurrence and metastasis, the 5-year survival rate of patients with advanced HCC does not exceed 5% [3]. The development of various targeted drugs has prolonged the survival of patients and made a revolutionary breakthrough in the treatment of advanced HCC. Even with sorafenib or regorafenib therapy, the overall life expectancy of HCC patients is less than www.aging-us.com

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call